1: Oblinger JL, Wang J, Wetherell GD, Agarwal G, Wilson TA, Benson NR, Fenger JM, Fuchs JR, Kinghorn AD, Chang LS. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas. Sci Rep. 2024 Aug 20;14(1):19349. doi: 10.1038/s41598-024-69171-3. PMID: 39164287; PMCID: PMC11335891.
2: Oblinger J, Wang J, Wetherell G, Agarwal G, Wilson T, Benson N, Fenger J, Fuchs J, Kinghorn AD, Chang L. Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas. Res Sq [Preprint]. 2024 Jun 14:rs.3.rs-4494024. doi: 10.21203/rs.3.rs-4494024/v1. Update in: Sci Rep. 2024 Aug 20;14(1):19349. doi: 10.1038/s41598-024-69171-3. PMID: 38947012; PMCID: PMC11213195.
3: Medica S, Crawford LB, Denton M, Min CK, Jones TA, Alexander T, Parkins CJ, Diggins NL, Streblow GJ, Mayo AT, Kreklywich CN, Smith P, Jeng S, McWeeney S, Hancock MH, Yurochko A, Cohen MS, Caposio P, Streblow DN. Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation. PLoS Pathog. 2023 Oct 2;19(10):e1011682. doi: 10.1371/journal.ppat.1011682. PMID: 37782657; PMCID: PMC10569644.
4: Yamada S, Yassin MA, Torelli F, Hansmann J, Green JBA, Schwarz T, Mustafa K. Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho-ROCK-mediated contractility dependent. Bioeng Transl Med. 2023 Mar 17;8(3):e10509. doi: 10.1002/btm2.10509. PMID: 37206242; PMCID: PMC10189446.
5: Li L, Xin J, Wang H, Wang Y, Peng W, Sun N, Huang H, Zhou Y, Liu X, Lin Y, Fang J, Jing B, Pan K, Zeng Y, Zeng D, Qin X, Bai Y, Ni X. Fluoride disrupts intestinal epithelial tight junction integrity through intracellular calcium- mediated RhoA/ROCK signaling and myosin light chain kinase. Ecotoxicol Environ Saf. 2023 Jun 1;257:114940. doi: 10.1016/j.ecoenv.2023.114940. Epub 2023 Apr 24. PMID: 37099960.
6: Dandamudi A, Seibel W, Tourdot B, Cancelas JA, Akbar H, Zheng Y. Structure- Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. Int J Mol Sci. 2023 Feb 19;24(4):4167. doi: 10.3390/ijms24044167. PMID: 36835579; PMCID: PMC9961652.
7: Beak M, Park S, Kim JH, Eom HJ, Lee HY, Kim YH, Lee J, Nam S. Second- Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer. Cancers (Basel). 2022 Mar 22;14(7):1604. doi: 10.3390/cancers14071604. PMID: 35406376; PMCID: PMC8997135.
8: Liu H, Zeng X, Ma Y, Chen X, Losiewicz MD, Du X, Tian Z, Zhang S, Shi L, Zhang H, Yang F. Long-term exposure to low concentrations of MC-LR induces blood-testis barrier damage through the RhoA/ROCK pathway. Ecotoxicol Environ Saf. 2022 May 1;236:113454. doi: 10.1016/j.ecoenv.2022.113454. Epub 2022 Mar 31. PMID: 35367887.
9: Zhang D, Zhu Y, Li Z, Luo M, Liang X, Wang A, Zhu H, Hu L, Li R. The role of Astragalus polysaccharides in promoting IEC-6 cell migration from polyamine- mediated Ca2+ regulation. Int J Biol Macromol. 2022 May 15;207:179-192. doi: 10.1016/j.ijbiomac.2022.02.109. Epub 2022 Feb 23. PMID: 35217086.
10: Somodi L, Beke Debreceni I, Kis G, Cozzolino M, Kappelmayer J, Antal M, Panyi G, Bárdos H, Mutch NJ, Muszbek L. Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles. J Thromb Haemost. 2022 May;20(5):1223-1235. doi: 10.1111/jth.15668. Epub 2022 Feb 21. PMID: 35146910; PMCID: PMC9303193.
11: Shivangi, Meena LS. A multifactorial assessment of the SRP pathway constituent FtsY as a vital mycobacterial constituent. Biotechnol Appl Biochem. 2022 Dec;69(6):2445-2453. doi: 10.1002/bab.2294. Epub 2022 Jan 8. PMID: 34837716.
12: Okamoto Y, Kitakaze K, Takenouchi Y, Yamamoto S, Ishimaru H, Tsuboi K. Sphingosine 1-phosphate receptor type 2 positively regulates interleukin (IL)-4/IL-13-induced STAT6 phosphorylation. Cell Signal. 2021 Dec;88:110156. doi: 10.1016/j.cellsig.2021.110156. Epub 2021 Sep 28. PMID: 34592416.
13: Sundberg M, Pinson H, Smith RS, Winden KD, Venugopal P, Tai DJC, Gusella JF, Talkowski ME, Walsh CA, Tegmark M, Sahin M. 16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro. Nat Commun. 2021 May 18;12(1):2897. doi: 10.1038/s41467-021-23113-z. PMID: 34006844; PMCID: PMC8131375.
14: Chiu WC, Chiang JY, Chiang FT. Small chemical compounds Y16 and Rhosin can inhibit calcium sensitization pathway in vascular smooth muscle cells of spontaneously hypertensive rats. J Formos Med Assoc. 2021 Oct;120(10):1863-1868. doi: 10.1016/j.jfma.2021.03.031. Epub 2021 Apr 21. PMID: 33893012.
15: Devi SS, Yadav R, Arya R. Altered Actin Dynamics in Cell Migration of GNE Mutant Cells. Front Cell Dev Biol. 2021 Mar 18;9:603742. doi: 10.3389/fcell.2021.603742. PMID: 33816461; PMCID: PMC8012676.
16: Tsubaki M, Genno S, Takeda T, Matsuda T, Kimura N, Yamashita Y, Morii Y, Shimomura K, Nishida S. Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells. Biomedicines. 2021 Jan 4;9(1):35. doi: 10.3390/biomedicines9010035. PMID: 33406809; PMCID: PMC7824767.
17: Ariyani W, Miyazaki W, Amano I, Hanamura K, Shirao T, Koibuchi N. Soy Isoflavones Accelerate Glial Cell Migration via GPER-Mediated Signal Transduction Pathway. Front Endocrinol (Lausanne). 2020 Nov 4;11:554941. doi: 10.3389/fendo.2020.554941. PMID: 33250856; PMCID: PMC7672195.
18: Privat M, Cavard A, Zekri Y, Ponelle-Chachuat F, Molnar I, Sonnier N, Bignon YJ. A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors. Int J Med Sci. 2020 Oct 1;17(17):2799-2808. doi: 10.7150/ijms.43101. PMID: 33162807; PMCID: PMC7645338.
19: Abramochkin DV, Filatova TS, Pustovit KB, Dzhumaniiazova I, Karpushev AV. Small G-protein RhoA is a potential inhibitor of cardiac fast sodium current. J Physiol Biochem. 2021 Feb;77(1):13-23. doi: 10.1007/s13105-020-00774-w. Epub 2020 Nov 4. PMID: 33145656.
20: Kim JH, Park S, Lim SM, Eom HJ, Balch C, Lee J, Kim GJ, Jeong JH, Nam S, Kim YH. Rational design of small molecule RHOA inhibitors for gastric cancer. Pharmacogenomics J. 2020 Aug;20(4):601-612. doi: 10.1038/s41397-020-0153-6. Epub 2020 Feb 4. PMID: 32015453.